Arima Genomics Closes Series A Financing

Represented Arima Genomics, Inc. in its $22 million of Series A Preferred Stock, Series B Preferred Stock and convertible bridge loan financing deals, led by investors Agilent Technologies, Inc., Co-win Healthcare Funds and Illumina Ventures.

Arima Genomics is a developer of a gene sequencing technology designed to accelerate the understanding of genome sequence and structure toward their role in human health and disease.